Tag: clinical trials

Identifying Critical-to-Quality Factors and Building Risk Registers

November 15, 2025November 15, 2025 digi

Identifying Critical-to-Quality Factors and Building Risk Registers Identifying Critical-to-Quality Factors and Building Risk Registers In the realm of clinical trials, understanding and managing risk is essential to ensuring product quality and patient safety. This article serves as a comprehensive guide for clinical operations, regulatory affairs, and medical affairs professionals focusing on risk assessment and the…

Risk Assessment & Risk Controls

Visit Management Fundamentals: Keeping Every Study Visit on Track

November 15, 2025November 15, 2025 digi

Visit Management Fundamentals: Keeping Every Study Visit on Track Visit Management Fundamentals: Keeping Every Study Visit on Track Introduction to Visit Management In clinical research, effective visit management is crucial to the success of a study. Managing study visits involves ensuring that each participant has a seamless experience while aligning with regulatory compliance requirements. This…

Visit Management & Source Documentation

Designing Source Documentation That Matches Protocol and GCP Expectations

November 15, 2025November 15, 2025 digi

Designing Source Documentation That Matches Protocol and GCP Expectations Designing Source Documentation That Matches Protocol and GCP Expectations In the context of clinical trials, proper documentation is a critical element that ensures compliance with regulatory expectations and facilitates accurate data collection. This article outlines a comprehensive guide for clinical research professionals on designing source documentation…

Visit Management & Source Documentation

Sponsor GCP Obligations: Oversight, Quality Management and Risk Control

November 15, 2025November 15, 2025 digi

Sponsor GCP Obligations: Oversight, Quality Management and Risk Control Sponsor GCP Obligations: Oversight, Quality Management and Risk Control Clinical trials are a fundamental part of the drug development process, providing the necessary evidence for regulatory approvals and subsequent market access. The obligations of sponsors under Good Clinical Practice (GCP) ensure the ethical and scientific integrity…

Sponsor & CRO GCP Obligations

CRO Responsibilities Under GCP: Where Outsourcing Ends and Accountability Remains

November 15, 2025November 15, 2025 digi

CRO Responsibilities Under GCP: Where Outsourcing Ends and Accountability Remains CRO Responsibilities Under GCP: Where Outsourcing Ends and Accountability Remains In the realm of clinical trials, the outsourcing of responsibilities to Contract Research Organizations (CROs) has become a prevalent practice amongst sponsors. Nevertheless, while outsourcing is commonplace, it is imperative that sponsors understand the regulatory…

Sponsor & CRO GCP Obligations

Clinical Risk Assessment Frameworks: From Study-Level to Program-Level

November 15, 2025November 15, 2025 digi

Clinical Risk Assessment Frameworks: From Study-Level to Program-Level Clinical Risk Assessment Frameworks: From Study-Level to Program-Level In today’s clinical research landscape, the importance of robust risk assessment frameworks cannot be overstated. For clinical operations, regulatory affairs, and medical affairs professionals in the US, UK, and EU, understanding how to implement these frameworks is crucial for…

Risk Assessment & Risk Controls

Rewarding and Recognizing Sites That Excel at Recruitment and Retention

November 15, 2025 digi

Rewarding and Recognizing Sites That Excel at Recruitment and Retention Rewarding and Recognizing Sites That Excel at Recruitment and Retention Introduction The landscape of clinical trials is constantly evolving, and the importance of efficient subject recruitment and retention cannot be overstated. Recruitment is not merely about enrolling participants; it involves strategic planning, proper execution, and…

Subject Screening, Enrollment & Retention

Post-Enrollment Engagement Tactics to Keep Subjects in Long Studies

November 15, 2025November 15, 2025 digi

Post-Enrollment Engagement Tactics to Keep Subjects in Long Studies Post-Enrollment Engagement Tactics to Keep Subjects in Long Studies In the realm of clinical trials, subject retention is a critical aspect that can influence both the integrity of the data collected and the overall success of the study. Long studies particularly face challenges with maintaining participant…

Subject Screening, Enrollment & Retention

PI Oversight When Using External Vendors, Labs and Home Health Providers

November 15, 2025November 15, 2025 digi

PI Oversight When Using External Vendors, Labs and Home Health Providers In the landscape of clinical research, Principal Investigators (PIs) are tasked with numerous responsibilities that extend beyond their immediate research teams. As clinical trials increasingly engage external vendors, laboratories, and home health service providers, understanding the PI’s oversight responsibilities becomes essential. This article provides…

Investigator Responsibilities under GCP

Strategies for PIs to Demonstrate Continuous GCP Compliance During Inspections

November 15, 2025November 15, 2025 digi

Strategies for PIs to Demonstrate Continuous GCP Compliance During Inspections Strategies for PIs to Demonstrate Continuous GCP Compliance During Inspections Ensuring compliance with Good Clinical Practice (GCP) is essential for Principal Investigators (PIs) overseeing clinical trials. This is especially crucial during inspections by regulatory authorities such as the FDA, EMA, and MHRA. In this tutorial,…

Investigator Responsibilities under GCP